Heraldnet.com
SATURDAY, JULY 4, 2009 11:36 am
LocalNorthwestNation & WorldPoliticsSpecial ReportsPhotosColumnistsMultimedia 
Blog
Michelle Dunlop
Tests continue on Boeing's 787
Your town news
Mike Benbow
Business editor Mike Benbow's insights into all things business.
•Latest: State's new commerce director shares his business principles
Steve Tytler
Steve Tytler answers your questions about real estate.
•Latest: New rules create an appraisal nightmare
 
WEEK IN REVIEW
Friday
Armed man shot by deputies in Arlington
Police ID make of vehicle in fatal hit-and-run
Boeing's 6-month tally: 1 net order
Thursday


One fire rips through $2 million home, another ...
Swine flu claims 2nd victim in Snohomish County
Jetty Island firefight continues; hot weather ...
Wednesday


Fire District 1 negotiates to take over service...
Snohomish County population rising fast since 2...
Honey's owners indicted by feds
Tuesday


Mobile home tenants along Snohomish River told ...
Lincoln to leave Everett in 2013
Put on your sailor's cap and explore Naval Stat...
Monday


Disabled people will be left without a ride
You'll soon have 4,500 reasons to trade in that...
Pay hike deserved, Monroe chief says
Sunday


1,670 local students in county are without homes
Monroe's business gets done in secret
$9 million to be sought for U.S. 2 in federal t...
Saturday


Use of local parks spikes
Gay-friendly shift at 2 churches
Racist graffiti scrawled on cars in Everett nei...
 

ADVERTISEMENT

Business   Print This Article  Email This Page  Subscribe Now! facebook digg reddit del.icio.us fark stumble

 
ADVERTISEMENT

 
CONTACT THE HERALD
Mike Benbow, Business Editor
benbow@heraldnet.com
 
Published: Friday, April 25, 2008

Seattle Genetics plans more clinical drug tests

BOTHELL -- Seattle Genetics earned more money from its big drug development partner during the first quarter, but the biotechnology firm's losses nearly doubled as expenses rose.

The Bothell-based developer of cancer drugs posted a net loss of $17.1 million, or 22 cents a share, compared to an $8.8 million loss in the year-ago period.

Clay Siegall, Seattle Genetics' president and chief executive officer, said the company's three leading drug candidates are moving well through clinical trials. Based on encouraging data, he said, the company is accelerating manufacturing and clinical development activities to further advance those drugs.

"We now have 10 trials ongoing across our portfolio and two more planned to start this year," Siegall said.

The company's lead drug candidate, SGN-40, is now in multiple trials. The start of its latest study triggered a $4 million payment from Genentech, which is helping Seattle Genetics develop the cancer drug.

That payment helped to push revenue during the period to $7.1 million, up from $4.3 million a year ago. Operating expenses totaled $26.1 million, up from $14.6 million because of expanded clinical trial costs. The company also has grown its research and development staff since last year.

But the biotech has plenty banked away to cover the costs, Siegall reported. As of March 31, Seattle Genetics had $216 million in cash and investments, which includes proceeds of $97.6 million from the company's public stock offering in January.

Reporter Eric Fetters: 425-339-3453 or fetters@heraldnet.com.

1. Snohomish County man dies of swine flu
2. Lynnwood bank reprimanded by government
3. Police ID make of vehicle in fatal hit-and-run
4. Armed man shot by deputies in Arlington
5. IRS joins puppy mill investigation
6. Jetty Island ready for sand castles
7. Boeing's 6-month tally: 1 net order
8. Warriors & Patriots: Many American Indians served before getting full citizenship rights
9. Movin' out
10. Marshals seize swindler's home
Enterprise Newspaper Snohomish County Business Journal
Warriors looking for balance
Three Scots vying for QB slot
Jackson looks for another title
Decorated veteran continues to serve as active volunteer
City Council reviewing sign regulations
Wildcats get a peek at newcomers
Lynnwood still in rebuilding mode
Shoreline feels a kindergarten growth spurt
Leave the patriotic pyrotechnics to professionals, cities urge
The Enterprise Online Newspaper

TODAY'S TOP JOBS
 View All Top Jobs 
Top Cars
Top Homes


ADVERTISEMENT